This week’s topics include hospital factors relative to readmission, hormone therapy, lymph node dissection in breast cancer, and the cost of bringing a new drug to market.
Program notes:
0:32 Cost of R and D versus profit in new drugs
1:32 Took 7.3 years
2:35 Reaping in sales far outstrips R and D
3:32 R and D with federal dollars
4:00 What is the long term impact of HRT
5:00 Should be reassuring for women
5:36 Lymph node dissection in breast cancer
6:36 Increases risk of complications
7:32 Least amount of therapy to be effective
7:48 Hospital factors in readmission
8:45 Patients readmitted to different hospitals
9:45 Need to correct poorly performing hospitals
10:31 End
Related blog: https://podblog.blogs.hopkinsmedicine.org/2017/09/18/drug-costs/
Podden och tillhörande omslagsbild på den här sidan tillhör Johns Hopkins Medicine. Innehållet i podden är skapat av Johns Hopkins Medicine och inte av, eller tillsammans med, Poddtoppen.
